24Serious

Shane O'Neill

Shane O'Neill

Ask VT AI

View News Summary

Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
MP Materials reports smaller Q2 loss as rare earth production surges 119%, boosted by government deals and rising demand.
Chicago approves historic 2025 river swim event, raising funds for ALS research and youth swim education.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
MP Materials reports smaller Q2 loss as rare earth production surges 119%, boosted by government deals and rising demand.
Chicago approves historic 2025 river swim event, raising funds for ALS research and youth swim education.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Shane O'Neill